These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31994337)

  • 21. Use of RNA biomarkers in the antidoping field.
    Loria F; Grabherr S; Kuuranne T; Leuenberger N
    Bioanalysis; 2024; 16(10):475-484. PubMed ID: 38497758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous steroid profiling in the athlete biological passport.
    Sottas PE; Saugy M; Saudan C
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):59-73, viii-ix. PubMed ID: 20122450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Next Generation "Omics" Approaches in the "Fight" against Blood Doping.
    Wang G; Karanikolou A; Verdouka I; Friedmann T; Pitsiladis Y
    Med Sport Sci; 2017; 62():119-128. PubMed ID: 28571016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New and old challenges of sports drug testing.
    Botrè F
    J Mass Spectrom; 2008 Jul; 43(7):903-7. PubMed ID: 18570180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The international antidoping system and why it works.
    Bowers LD
    Clin Chem; 2009 Aug; 55(8):1456-61. PubMed ID: 19556445
    [No Abstract]   [Full Text] [Related]  

  • 26. A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
    Harcourt PR; Marclay F; Clothier B
    Br J Sports Med; 2014 May; 48(10):810-3. PubMed ID: 24642697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indirect biomarkers of blood doping: A systematic review.
    Krumm B; Saugy JJ; Botrè F; Donati F; Faiss R
    Drug Test Anal; 2024 Jan; 16(1):49-64. PubMed ID: 37160638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The athlete biological passport.
    Sottas PE; Robinson N; Rabin O; Saugy M
    Clin Chem; 2011 Jul; 57(7):969-76. PubMed ID: 21596947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemoglobin mass and biological passport for the detection of autologous blood doping.
    Pottgiesser T; Echteler T; Sottas PE; Umhau M; Schumacher YO
    Med Sci Sports Exerc; 2012 May; 44(5):835-43. PubMed ID: 21988933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Athlete Biological Passport from the perspective of an anti-doping organization.
    Zorzoli M
    Clin Chem Lab Med; 2011 Sep; 49(9):1423-5. PubMed ID: 21726163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel antidoping and medical care delivery model at the 2nd Summer Youth Olympic Games (2014), Nanjing China.
    Mountjoy M; Akef N; Budgett R; Greinig S; Li G; Manikavasagam J; Soligard T; Haiming X; Yang X
    Br J Sports Med; 2015 Jul; 49(13):887-92. PubMed ID: 25833900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-dope testing in sport: the history and the science.
    Bowers LD
    FASEB J; 2012 Oct; 26(10):3933-6. PubMed ID: 23028114
    [No Abstract]   [Full Text] [Related]  

  • 33. Altitude exposure in sports: the Athlete Biological Passport standpoint.
    Sanchis-Gomar F; Pareja-Galeano H; Brioche T; Martinez-Bello V; Lippi G
    Drug Test Anal; 2014 Mar; 6(3):190-3. PubMed ID: 24115763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of autologous blood transfusions in athletes: a historical perspective.
    Mørkeberg J
    Transfus Med Rev; 2012 Jul; 26(3):199-208. PubMed ID: 22119492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidoping control in Brazil: history, current situation, and prospects for the 2014 World Cup and the 2016 Olympic Games.
    Santos MA; Silva AS; Ribeiro SL; Santos AM
    Subst Use Misuse; 2014 Jul; 49(9):1152-5. PubMed ID: 24832912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in blood parameters after intramuscular testosterone ester injections - Implications for anti-doping.
    Solheim SA; Mørkeberg J; Dehnes Y; Hullstein I; Juul A; Upners EN; Nordsborg NB
    Drug Test Anal; 2020 Aug; 12(8):1019-1030. PubMed ID: 32307878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time for change: a roadmap to guide the implementation of the World Anti-Doping Code 2015.
    Dvorak J; Baume N; Botré F; Broséus J; Budgett R; Frey WO; Geyer H; Harcourt PR; Ho D; Howman D; Isola V; Lundby C; Marclay F; Peytavin A; Pipe A; Pitsiladis YP; Reichel C; Robinson N; Rodchenkov G; Saugy M; Sayegh S; Segura J; Thevis M; Vernec A; Viret M; Vouillamoz M; Zorzoli M
    Br J Sports Med; 2014 May; 48(10):801-6. PubMed ID: 24764550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study.
    Pottgiesser T; Sottas PE; Echteler T; Robinson N; Umhau M; Schumacher YO
    Transfusion; 2011 Aug; 51(8):1707-15. PubMed ID: 21382045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-dependent testosterone sensitivity of the steroidal passport and GC-C-IRMS analysis in relation to the UGT2B17 deletion polymorphism.
    Strahm E; Mullen JE; Gårevik N; Ericsson M; Schulze JJ; Rane A; Ekström L
    Drug Test Anal; 2015; 7(11-12):1063-70. PubMed ID: 26198073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of gas chromatography/quadrupole time-of-flight and quadrupole Orbitrap mass spectrometry in anti-doping analysis: I. Detection of anabolic-androgenic steroids.
    Abushareeda W; Tienstra M; Lommen A; Blokland M; Sterk S; Kraiem S; Horvatovich P; Nielen M; Al-Maadheed M; Georgakopoulos C
    Rapid Commun Mass Spectrom; 2018 Dec; 32(23):2055-2064. PubMed ID: 30216576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.